A novel empeROR of pancreatic malignancy
How pancreatic cancer cells acquire tumor initiating capacities remains poorly understood. A recent study by Yamazaki et al (2023) uncovers a crucial, targetable role of tyrosine kinase-like orphan receptor (ROR1) in PDAC tumor formation and progression.
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/217250 |
| Acceso en línea: | https://hdl.handle.net/2445/217250 |
| Access Level: | acceso abierto |
| Palabra clave: | Càncer de pàncrees Receptors cel·lulars Cèl·lules canceroses Diagnòstic molecular Pancreas cancer Cell receptors Cancer cells Molecular diagnosis |
| Sumario: | How pancreatic cancer cells acquire tumor initiating capacities remains poorly understood. A recent study by Yamazaki et al (2023) uncovers a crucial, targetable role of tyrosine kinase-like orphan receptor (ROR1) in PDAC tumor formation and progression. |
|---|